Approving a skincare formula is an important milestone, but it does not by itself make a project ready for bulk production. Before manufacturing starts, the brand and manufacturer should be working from the same production basis: the exact product reference, packaging, artwork, SKU quantities, and order scope for the order.

A useful way to think about this is a production lock. It is not a universal industry certificate, regulatory step, or formal Rixin procedure. It is a practical buyer-side checkpoint: the production inputs are clear, production-blocking questions are resolved, and any non-blocking follow-up has a named owner.

This pre-production check is the starting point in the wider production-readiness lifecycle, which continues through approved changes, finished-goods handoff, and repeat orders.

What “Production Ready” Means

A project is not production-ready just because one part of it is approved. Formula, packaging, artwork, quantity, and project-specific evidence questions can move on different timelines.

Use three simple statuses:

  • Ready: the production input is confirmed, and any requirements that must be completed before this production step have been cleared through the responsible review.
  • Open: a required decision, review, or production-blocking item remains unresolved, even if its owner and status are known.
  • Changed: a previously approved input has been revised and may need its readiness checked again.

For each item, also record who owns the confirmation and what evidence or status source shows the current position. That evidence does not need to be the same document for every project; it may be an approved reference, current artwork file, confirmed order record, or project-specific review status.

Production input Ready when Open or changed when Owner / evidence to record
Formula / product reference One current product basis is clear Approval is incomplete or the approved basis changed Brand and manufacturer project owners; current approved formula/sample/reference
Packaging Final production direction is clear Component, fit, or package decision is unresolved or changed Relevant brand/manufacturer packaging owner; confirmed package/component reference
Artwork Current production version is confirmed File or review is not final, or the version changed Brand artwork owner and relevant manufacturer/packaging owner; current approved artwork version
SKU / quantity Current SKU set and quantities are confirmed SKU, size, quantity, or order scope remains unresolved or changed Brand purchasing/project owner and manufacturer project owner; current order record
Testing / documents Applicable pre-production requirements are completed, or a responsible qualified review confirms and records that a pending item does not block this production step A required pre-production item is unresolved, its blocking effect is unknown, or a change requires renewed review Relevant technical, quality, or regulatory owner; current test/document/review status and clearance decision

The important rule is simple: if an unresolved item could change what is manufactured, how it is packed or labeled, the SKU/order scope, or a required project review, keep it Open until it is resolved or an appropriate qualified reviewer has documented why it does not block this production step.

Confirm the Exact Product Reference

Formula approval answers one question: has the brand accepted the current formula direction?

It does not automatically confirm the other production inputs. If you are still evaluating texture, sensory performance, or formula revisions, the project belongs in the sampling and formula approval stage rather than bulk production.

Once the formula direction is accepted, remove ambiguity about the exact product reference. The brand and manufacturer should be referring to the same current formula, approved sample or other agreed product reference for that SKU.

Approved skincare sample and production-direction package are compared as one current product reference before manufacturing.

A simple version-control example looks like this:

Formula: latest approved reference. Packaging: confirmed component. Artwork: approved file version. Order: confirmed SKU and quantity. Testing or documentation: status and owner recorded.

This matters because the product name can stay the same while a fragrance, texture, fill size, or another detail changes. If the exact reference is unclear, treat the item as open, not ready.

Confirm Packaging and Artwork Separately

Formula, packaging, and artwork should not be treated as one approval.

A formula can be accepted while a pump, bottle, jar, tube, closure, carton, label, decoration method, or artwork file still needs review. Packaging can also affect filling, dispensing, whether components fit and work as intended, decoration, and the information that appears on the finished unit.

Before bulk production, confirm which packaging system and which artwork version belong to the order. If a package-fit question, component decision, or artwork review is still unresolved, keep it open rather than assuming formula approval closed it.

Skincare bottle, closure, carton, and artwork proof are reviewed together before bulk production.

Detailed packaging work belongs in Packaging and Label Design. This article only needs the production-readiness decision: is the current packaging and artwork basis clear enough for this order to proceed?

If something already approved has changed, do not assume the previous approval still covers the new version automatically.

Confirm SKU Quantities and Order Scope

Production also needs one current order basis.

Confirm the SKU set and quantity for each SKU, together with the order details that define what is being manufactured. If a project contains several formulas, sizes, packaging versions, or artwork versions, the order should make those distinctions clear.

Avoid sending an order into production while material to-be-confirmed (TBC) decisions still affect what must be made.

A commercially agreed quantity does not make the rest of the project ready. Packaging, artwork, product reference, or a project-specific review may still be open.

MOQ and timing remain separate questions. Use the MOQ and Lead Time guide for the current minimum-order and production-period definitions rather than repeating them here.

Identify Open Testing, Documentation, or Market Dependencies

Not every skincare project requires the same tests, documents, or market review. What is relevant can depend on the product, packaging, claims, target market, project scope, and which responsibilities sit with the brand, manufacturer, or another reviewer.

The buyer therefore needs more than a list of possible tests. For every relevant item, record:

  1. Owner — who is responsible for confirming the status?
  2. Status — not required, planned/pending, completed/available, or still unclear?
  3. Evidence/source — what current record, result, file, or reviewer confirmation supports that status?
  4. Blocking effect — has an appropriate qualified reviewer confirmed that the requirement is complete before this production step, or documented why a pending item does not block it? A known status without this decision remains Open.

Applicable technical, quality, or regulatory reviewers should confirm project-specific requirements where needed. “Not every project requires the same tests” should never be interpreted as permission to ignore a requirement that actually applies to the project.

For deeper testing, documentation, and responsibility boundaries, use Quality Testing and Documentation.

Resolve Blocking Items Before Production

The Ready / Open / Changed framework is useful only if it leads to a clear decision.

Before bulk production starts, review every open or changed input and ask:

  • Could this change the formula or product reference?
  • Could it change the packaging or artwork used in production?
  • Could it change the SKU, quantity, fill size, or order scope?
  • Could it change a project-specific test, document, or market-review requirement?

If the answer is yes, the item should be resolved before production starts.

If the item does not block production, record that decision, the responsible owner, and the follow-up status. Assigning an owner by itself is not enough to clear a production-critical issue.

Changes after approval should also be reviewed separately from the initial readiness check; a changed input may reopen decisions that were previously closed.

What Happens After the Production Basis Is Confirmed?

Once the relevant inputs are confirmed and production-blocking questions are closed, the project can move into the manufacturing stages that apply to that order. Depending on the project, this may include material and component preparation, manufacturing, filling or assembly, the quality checks agreed for that project, packing, and shipment preparation.

The actual factory process belongs on the Manufacturing Facility page.

Before treating a skincare project as ready for bulk production, ask one final question:

Are the brand and manufacturer working from the same current product and order basis, with every production-blocking item resolved and every non-blocking follow-up clearly assigned and recorded?

If the answer is yes, the project has a much clearer basis for moving from approval into bulk manufacturing.